Accelerate Clinical Trials Research Gr... - Lung Cancer Support

Lung Cancer Support

3,998 members2,164 posts

Accelerate Clinical Trials Research Grant Awarded!

FtB_Travis profile image
1 Reply

Free to Breathe is pleased to announce the winners of the 2016 Accelerate Clinical Trials Research Grant Award!

Co-investigators Amy Leader, DrPH, MPH, and Ralph Zinner, MD of the Sidney Kimmel Cancer Center at Thomas Jefferson University have been awarded the ACT grant award for their research in using Decision Aids (DA) to provide patients with information and to assist with important health decisions. Scott Cowan, MD, Associate Professor, Cardiothoracic Surgery, is also a co-investigator and will be an integral part of the study through his clinical expertise working with patients with lung cancer.

The ACT grant was started in 2015 with the purpose of funding pilot research projects that will investigate strategies to improve accrual of patients with lung cancer to therapeutic clinical trials.

Read more about their research here: freetobreathe.org/about-us/...

Written by
FtB_Travis profile image
FtB_Travis
To view profiles and participate in discussions please or .
Read more about...
1 Reply
scifiknitter profile image
scifiknitterBlogger

This is great news. We need some good decision aids in our clinics - this will fill a real patient need.

Anita

You may also like...

The Wind Beneath My Wings Caregiver Award

Behind every lung cancer patient stands a caregiver walking together with their loved one diagnosed...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

non-small cell lung cancer (NSCLC) that has been surgically removed, when the cancer has a change in

Has anyone received the Covid-19 Vaccine while taking Immunotherapy?

and other patients have been receiving this therapy longer than metastatic lung cancer patients...

Oncologist Versus Clinics

properly and by the right person. My cancer hospital works by separate clinics and I just went...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

approval on the results of the clinical trial IMpower-110 which showed that patients receiving...